Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
ELVN
#1718
Enliven Therapeutics, Inc. Common Stock
29.690
0
+2.63%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
+2.63%
Monatliche Änderung
+13.58%
6 month change
+43.71%
Jahresänderung
+43.71%
Vorheriger Schlusskurs
28.930
0
Open
29.700
0
Bid
Ask
Low
29.690
0
High
29.700
0
Volumen
140
Märkte
Aktien
Gesundheitswesen
ELVN
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
17.58 M
26.29 M
26.23 M
41.35 M
49 M
—
Valuation ratios
Enterprise value
—
—
—
515.94 M
978.48 M
4.02 B
Price to earnings ratio
—
—
—
-7.41
-11.9
-43.31
Price to sales ratio
—
—
—
—
96.28 K
—
Price to cash flow ratio
—
—
—
8.64
14.47
56.17
Price to book ratio
—
—
—
2.15
3.42
5.64
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.46
0.55
0.02
0.26
0.27
0.26
Return on equity %
0.49
0.6
0.02
0.29
0.29
0.27
Return on invested capital %
51.61 K
33.32 K
156.69
2 319.69
1 935.13
2 536.97
Gross margin %
—
—
100
—
100
—
Operating margin %
—
—
4 562.5
—
950.49 K
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
9 300
—
809.31 K
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
14.47
12.86
48.98
10.28
19.99
106.58
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
—
0
—
0
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
1.35
1.72
1.55
1.39
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
—
3.34
7.12
6.66
29.55
Net current asset value per share
—
—
3.4
7.49
6.76
29.92
Tangible book value per share
—
—
3.42
6.92
6.58
29.38
Working capital per share
—
—
3.33
6.76
6.42
28.78
Book value per share
—
—
3.42
6.92
6.58
29.38
Nachrichten
Heyman, Enliven Therapeutics director, sells $32k in stock
Lyssikatos, Enliven Therapeutics CSO, sells $145k in shares
Enliven Therapeutics: CSO Lyssikatos verkauft Aktien im Wert von 535.000 US-Dollar
Lyssikatos, Enliven Therapeutics CSO, sells $535k in ELVN stock
Enliven Therapeutics: Direktor Heyman veräußert Aktien im Wert von 32.901 US-Dollar
Enliven Therapeutics director Heyman sells $32,901 in stock
Enliven Therapeutics: COO Anish Patel verkauft Aktien im Wert von 1,35 Mio. US-Dollar
Anish Patel, COO of Enliven Therapeutics, sells $1.35m in ELVN
Enliven Therapeutics: Springing Into 2026 With Data, But I'm Still Cautious
Nach Kursrallye: CSO von Enliven Therapeutics verkauft Aktien im Wert von 3,47 Mio. $
Enliven Therapeutics CSO Lyssikatos sells $3.47 million in shares
Aktie von Enliven Therapeutics erreicht 52-Wochen-Hoch bei 25,64 USD/n